$2.11
0.01000.48%
At Close: -
$2.06
-0.05-2.37%
After Hours: 8:59 AM EDT
15 minutes delayed
AN2 Therapeutics
ANTXNASDAQ
AN2 Therapeutics (ANTX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAN2 Therapeutics (NASDAQ:ANTX) Stock Quotes, Forecast and News Summary
AN2 Therapeutics Stock (NASDAQ: ANTX) stock price, news, charts, stock research, profile.
| Open | $2.10 |
| Close | $2.11 |
| Volume / Avg. | 197.20K / 201.12K |
| Day Range | 2.10 - 2.19 |
| 52 Wk Range | 1.91 - 22.22 |
| Market Cap | $61.45M |
| P/E Ratio | - |
| Dividend Yield | - |
| Quote.Metrics.exchange | NASDAQ |
| RSI | 50 |
| Short Interest | 3.88% |
| Days to Cover | 3.16 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy AN2 Therapeutics (ANTX) stock?
You can purchase shares of AN2 Therapeutics (NASDAQ:ANTX) through any online brokerage.
Who are AN2 Therapeutics (ANTX) competitors?
Other companies in AN2 Therapeutics’s space includes: SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Ocuphire Pharma (NASDAQ:OCUP), Lipocine (NASDAQ:LPCN) and Marinus Pharma (NASDAQ:MRNS).
What is the target price for AN2 Therapeutics (ANTX) stock?
There is no analysis for AN2 Therapeutics.
What is the forecast for AN2 Therapeutics (ANTX) stock?
AN2 Therapeutics has a consensus price target of $8.86.
Current stock price for AN2 Therapeutics (ANTX)?
The stock price for AN2 Therapeutics (NASDAQ: ANTX) is $2.06 last updated June 26, 2024 at 8:59 AM EDT.
Does AN2 Therapeutics (ANTX) pay a dividend?
A quarterly cash dividend of 0.66 per share of Class A Common Stock. The quarterly cash dividend was payable on February 1, 2018 to stockholders of record on January 11, 2018.
When is AN2 Therapeutics (NASDAQ:ANTX) reporting earnings?
AN2 Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
Is AN2 Therapeutics (ANTX) going to split?
There is no upcoming split for AN2 Therapeutics.
What sector and industry does AN2 Therapeutics (ANTX) operate in?
AN2 Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.